Stocks and InvestingStocks and Investing
Wed, November 24, 2021
Tue, November 23, 2021
Mon, November 22, 2021
Sun, November 21, 2021
Sat, November 20, 2021
Fri, November 19, 2021

Brian Abrahams Maintained (BIIB) at Hold with Decreased Target to $277 on, Nov 19th, 2021


Published on 2024-10-27 18:42:58 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $295 to $277 on, Nov 19th, 2021.

Brian has made no other calls on BIIB in the last 4 months.



There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 3 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $270 on, Tuesday, October 26th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $327 on, Friday, October 15th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $290 on, Friday, October 8th, 2021


These are the ratings of the 8 analyists that currently disagree with Brian


  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $386 on, Thursday, October 21st, 2021
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $390 on, Thursday, October 21st, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $440 on, Thursday, October 21st, 2021
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $375 on, Thursday, October 21st, 2021
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $344 on, Friday, October 15th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $442 on, Thursday, September 16th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $423 on, Tuesday, July 27th, 2021